Q&A: Genentech's Zemin Zhang on Whole-Genome Sequencing of Lung Cancer Samples
June 01, 2010
Q&A: Genentech's Zemin Zhang on Whole-Genome Sequencing of Lung Cancer Samples
Last week, researchers at Genentech led by Zemin Zhang, together with their collaborators at Complete Genomics, published an analysis of the genome of a lung tumor in Nature.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Complete Genomics Signs Two Contracts Worth $14M as Falling Prices Impact Q2 Revenues
August 9, 2011 / In Sequence - Paired Ends
June 28, 2011 / In Sequence - Complete Genomics Offers 4.5M Shares of Common Stock; Signs $20M Loan Agreement
May 17, 2011 / In Sequence - Complete Genomics Sees Future in Cancer Genome Sequencing; Plans New Cancer-Specific Product
March 16, 2011 / Clinical Sequencing News - Complete Genomics Partners with DNAnexus to Provide Cloud-Based Data Storage, Analysis
March 15, 2011 / In Sequence